212 related articles for article (PubMed ID: 8138394)
1. The molecular basis of secondary hyperparathyroidism in chronic renal failure.
Rahamimov R; Silver J
Isr J Med Sci; 1994 Jan; 30(1):26-31. PubMed ID: 8138394
[TBL] [Abstract][Full Text] [Related]
2. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
[TBL] [Abstract][Full Text] [Related]
3. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
[No Abstract] [Full Text] [Related]
4. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
Morio K; Koide K
Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
[TBL] [Abstract][Full Text] [Related]
5. Renal osteodystrophy and vitamin D derivatives: cellular mechanisms of hyperparathyroidism in uremia.
Fukagawa M; Kurokawa K
J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():96-9. PubMed ID: 1338454
[TBL] [Abstract][Full Text] [Related]
6. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
7. Regulation of parathyroid cell gene expression in experimental uremia.
Shvil Y; Naveh-Many T; Barach P; Silver J
J Am Soc Nephrol; 1990 Jul; 1(1):99-104. PubMed ID: 2104257
[TBL] [Abstract][Full Text] [Related]
8. Normocalcemic hyperparathyroidism associated with relatively low 1:25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol.
Lobo PI; Cortez MS; Stevenson W; Pruett TL
Clin Transplant; 1995 Aug; 9(4):277-81. PubMed ID: 7579733
[TBL] [Abstract][Full Text] [Related]
9. Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure.
Lopez-Hilker S; Galceran T; Chan YL; Rapp N; Martin KJ; Slatopolsky E
J Clin Invest; 1986 Oct; 78(4):1097-102. PubMed ID: 3760186
[TBL] [Abstract][Full Text] [Related]
10. Secondary hyperparathyroidism in chronic renal failure.
Wills MR; Savory J
Ann Clin Lab Sci; 1981; 11(3):252-61. PubMed ID: 6264838
[TBL] [Abstract][Full Text] [Related]
11. Regulation of parathyroid hormone synthesis in chronic renal failure in rats.
Fukagawa M; Kaname S; Igarashi T; Ogata E; Kurokawa K
Kidney Int; 1991 May; 39(5):874-81. PubMed ID: 2067203
[TBL] [Abstract][Full Text] [Related]
12. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism.
Reichel H; Deibert B; Schmidt-Gayk H; Ritz E
Nephrol Dial Transplant; 1991; 6(3):162-9. PubMed ID: 1866044
[TBL] [Abstract][Full Text] [Related]
13. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
Korkor AB
N Engl J Med; 1987 Jun; 316(25):1573-7. PubMed ID: 3035373
[TBL] [Abstract][Full Text] [Related]
14. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure.
St John A; Thomas MB; Davies CP; Mullan B; Dick I; Hutchison B; van der Schaff A; Prince RL
Nephron; 1992; 61(4):422-7. PubMed ID: 1501739
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of secondary hyperparathyroidism in chronic renal insufficiency.
Portale AA; Morris RC
Miner Electrolyte Metab; 1991; 17(4):211-20. PubMed ID: 1813783
[TBL] [Abstract][Full Text] [Related]
16. [Parathormone, calcitonin, 25-hydroxycalciferol and bone histology in patients with chronic renal insufficiency].
Kokot F; Kuska J; Sledziński Z; Białas B; Luciak M
Z Gesamte Inn Med; 1979 Nov; 34(22):665-70. PubMed ID: 549299
[TBL] [Abstract][Full Text] [Related]
17. Effects of high dialysate calcium concentration on bone remodelling, serum biochemistry, and parathyroid hormone in patients with renal osteodystrophy.
Drüeke T; Bordier PJ; Man NK; Jungers P; Marie P
Kidney Int; 1977 Apr; 11(4):267-74. PubMed ID: 857076
[TBL] [Abstract][Full Text] [Related]
18. Effect of the mode of calcitriol administration on PTH-ionized calcium relationship in uraemic patients with secondary hyperparathyroidism.
Caravaca F; Cubero JJ; Jimenez F; López JM; Aparicio A; Cid MC; Pizarro JL; Liso J; Santos I
Nephrol Dial Transplant; 1995; 10(5):665-70. PubMed ID: 7566580
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
[TBL] [Abstract][Full Text] [Related]
20. Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol.
Rodriguez M; Martin-Malo A; Martinez ME; Torres A; Felsenfeld AJ; Llach F
Kidney Int; 1991 Dec; 40(6):1055-62. PubMed ID: 1762306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
